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Available online 30 January 2015A recent case on spreading occult uterine leiomyosarcoma in a
patient with uterine ﬁbroids has given rise to a discussion on the
use of power morcellators in gynecology. For this reason, the Asia-
Paciﬁc Association for Gynecology Endoscopy and Minimally
Invasive Therapy (APAGE) recognizes the need to share available
guidance with gynecologists so as to provide safe and high-quality
care to patients.We have reviewed and analyzed available scientiﬁc
evidence on power morcellation and occult malignancy in the gy-
necologic ﬁeld. Our conclusions are listed below:
 Over the past 20 years, endoscopic minimally invasive surgery
(MIS) has been proven to be a safe and feasible procedure in
gynecology.1e5 The beneﬁts of MIS are well-documented in
retrospective and prospective studies.6e9 Compared to con-
ventional laparotomy, MIS has the advantages of small incisions,
less postoperative pain, shorter hospital stay, and faster recov-
ery. All these improve the quality of life of patients.
 With minimal access (small incision site), an MIS approach
would involve a variety of specialized instruments or techniques
such as the use of power morcellators during hysterectomy or
myomectomy.1,10 It has not been reported if there is a single
technique that is superior or is fully essential to MIS. Therefore,
all current techniques should remain available during surgery
before evidence-based guidelines are published on this topic.
 As the treatment options of tissue extraction continue to grow
with emerging technologies, there is a variety of techniques that
can be used to divide and remove the specimen. The manual
methods of specimen retrieval can be performed through the
vagina, through a minilaparotomy (abdominal incision about
5e6 cm), or through the umbilicus port sites.1,7,8,10 Power mor-
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incision site. However, it does have the potential to disseminate
uterine tissue throughout the peritoneal cavity. It is estimated
that less than one in 350 women who undergo hysterectomy or
myomectomy for uterine ﬁbroids may have an undetected type
of uterine malignancy.6,11
 Certain types of uterine cancer, such as leiomyosarcoma (LMS),
are rare. Although the overall incidence of uterine LMS in sur-
gical cases is very low (approximately 1:350),6 it has a poor
prognosis and high risk of recurrence even when the tissue is
removed intact. In fact, due to its complex biology, it is difﬁcult
to perform an assessment to diagnose a LMS preoperatively.12,13
The literature supports the fact that LMS is not easily diagnosed
or managed.12,13
 APAGE believes that there are various options of tissue extrac-
tion available and each option has its own beneﬁts. It is not
encouraged to convert all surgical cases to laparotomy so as to
avoid the use of power morcellators as the incidence of uterine
malignancy is very low (1:350).6,11,12
 Based on the current evidence, the management of benign and
malignant disease with MIS is much preferred over the tradi-
tional laparotomy approach. However, surgeons without the
requisite training and skills when performing laparoscopic
surgeries may lead to morcellator-related injuries and worsen
the patient's outcome. Therefore, proper training is required for
surgeons when using power morcellation device.
Thus, it is important for health care professionals to discuss the
risks, beneﬁts, and alternatives of all procedures with patients.
Health care facilities should provide appropriate information so
that patients are able to make an informed decision about accept-
ing or declining the options of treatment. APAGE will keep its
members up to date with regards to the latest development on this
topic. In addition, we would further enhance and improve the
safety of MIS to minimize harm to patients.References
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